These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38536822)

  • 21. [Influencing factors for the development and severity of bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks and a birth weight of <1 500 g].
    Huang J; Lin XZ; Zheng Z; Wang L; Ou FF
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1326-1333. PubMed ID: 36544414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with the response to postnatal dexamethasone use in very low birthweight infants: a nationwide cohort study.
    Baek SH; Shin JE; Han J; Song IG; Park J; Lee SM; Shim S; Eun HS; Lee SM; Lim J; Yoon SJ; Chang W; Park MS
    BMJ Paediatr Open; 2023 Dec; 7(1):. PubMed ID: 38114242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural History of Postnatal Cardiopulmonary Adaptation in Infants Born Extremely Preterm and Risk for Death or Bronchopulmonary Dysplasia.
    Mirza H; Garcia JA; Crawford E; Pepe J; Zussman M; Wadhawan R; Oh W
    J Pediatr; 2018 Jul; 198():187-193.e1. PubMed ID: 29625730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for neonatal bronchopulmonary dysplasia in extremely preterm premature rupture of membranes: a retrospective study.
    Nakamura E; Matsunaga S; Ono Y; Takai Y; Seki H
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):662. PubMed ID: 33143671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between early postnatal body weight changes and lung ultrasound scores as predictors of bronchopulmonary dysplasia in preterm infants: A secondary analysis of a prospective study.
    Ghanem M; Zozaya C; Ibrahim J; Lee S; Mohsen N; Nasef N; Mohamed A
    Eur J Pediatr; 2024 May; 183(5):2123-2130. PubMed ID: 38363393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of achieving perinatal interventions on bronchopulmonary dysplasia in preterm infants.
    Chen X; Yuan L; Jiang S; Gu X; Lei X; Hu L; Xiao T; Zhu Y; Dang D; Li W; Cao Y; Du L; Lee SK; Chen C; Zhou W; Zhou J;
    Eur J Pediatr; 2024 Apr; 183(4):1711-1721. PubMed ID: 38231237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRIB scores as a tool for assessing risk for the development of pulmonary hypertension in extremely preterm infants with bronchopulmonary dysplasia.
    Bruno CJ; Meerkov M; Capone C; Vega M; Sutton N; Kim M; Wang D; Fuloria M
    Am J Perinatol; 2015 Sep; 32(11):1031-7. PubMed ID: 26368789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early histological changes of bronchopulmonary dysplasia and pulmonary hypertension may precede clinical diagnosis in preterm infants.
    Stone A; Poulik J; Koussa S; Xin Y; Sharma A; Sood BG
    Early Hum Dev; 2022 Aug; 171():105612. PubMed ID: 35797784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
    Gentle SJ; Travers CP; Clark M; Carlo WA; Ambalavanan N
    Am J Respir Crit Care Med; 2023 Apr; 207(7):921-928. PubMed ID: 36378949
    [No Abstract]   [Full Text] [Related]  

  • 31. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
    Rodríguez-Blanco S; Oulego-Erroz I; Alonso-Quintela P; Terroba-Seara S; Jiménez-González A; Palau-Benavides M
    Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical burden of extremely preterm birth in a large medical records database in the United States: complications, medication use, and healthcare resource utilization.
    Siffel C; Hirst AK; Sarda SP; Chen H; Ferber J; Kuzniewicz MW; Li DK
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10271-10278. PubMed ID: 36170979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; De Jaegere AP; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermittent Hypoxemia and Bronchopulmonary Dysplasia with Pulmonary Hypertension in Preterm Infants.
    Gentle SJ; Travers CP; Nakhmani A; Indic P; Carlo WA; Ambalavanan N
    Am J Respir Crit Care Med; 2023 Apr; 207(7):899-907. PubMed ID: 36449386
    [No Abstract]   [Full Text] [Related]  

  • 35. The value of hematocrit for predicting bronchopulmonary dysplasia in very low birth weight preterm infants.
    Wang X; Wang S; Chen M; Lv Y; Chen X; Yang C
    Medicine (Baltimore); 2023 Sep; 102(39):e35056. PubMed ID: 37773858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of early risk prediction models for bronchopulmonary dysplasia in preterm infants.
    Zhang R; Xu FL; Li WL; Qin FY; Jin XY; Zhang Y; Zhang C; Zhu C
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):994-1001. PubMed ID: 34719413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Early Prediction Model for Estimating Bronchopulmonary Dysplasia in Preterm Infants.
    Kostekci YE; Bakırarar B; Okulu E; Erdeve O; Atasay B; Arsan S
    Neonatology; 2023; 120(6):709-717. PubMed ID: 37725910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors and machine learning prediction models for bronchopulmonary dysplasia severity in the Chinese population.
    He W; Zhang L; Feng R; Fang WH; Cao Y; Sun SQ; Shi P; Zhou JG; Tang LF; Zhang XB; Qi YY
    World J Pediatr; 2023 Jun; 19(6):568-576. PubMed ID: 36357648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors.
    Kiciński P; Kęsiak M; Nowiczewski M; Gulczyńska E
    Pol Merkur Lekarski; 2017 Feb; 42(248):71-75. PubMed ID: 28258680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of an Online Risk Estimator for Bronchopulmonary Dysplasia in Predicting Corticosteroid Treatment in Infants Born Preterm.
    Cuna A; Liu C; Govindarajan S; Queen M; Dai H; Truog WE
    J Pediatr; 2018 Jun; 197():23-28.e2. PubMed ID: 29551313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.